Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment. Finsterer J. J Infect Dis 2024;229:918-919.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Finsterer J. Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment. J Infect Dis 2024;229:918-919.
PMID: 38036417